Atreleuton
Based on 1 Customer Validation
Atreleuton (ABT-761) is a selective, reversible, and orally bioavailable 5-Lipoxygenase (5-LO) inhibitor. Atreleuton (ABT-761) exhibits potent and selective inhibition of leukotriene formation. Atreleuton is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.9%
- CAS. Nr.: 154355-76-7
- Formel: C16H15FN2O2S
- Molecular Weight:318.37
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
HY-12886
DocebenoneLipoxygenase Inhibitor -
HY-17492
ZafirlukastLeukotriene Receptor Antagonist -
HY-13315A
MontelukastCysLT1 Antagonist -
HY-14164
Zileuton5-Lipoxygenase Inhibitor -
HY-12341
Onvoloxastat12-LOX Inhibitor -
HY-113465
Leukotriene E4Cysteinyl Leukotriene Pathway Marker -
HY-121585
CAY1069812-LOX Inhibitor -
HY-14166
MK-886FLAP Inhibitor -
HY-113456
Leukotriene D4Bronchoconstrictor -
HY-110399
CirsiliolLipoxygenase Inhibitor -
HY-14164R
Zileuton (Standard)5-Lipoxygenase Inhibitor -
HY-117048
PF-41918345-LOX Inhibitor
Biologische Aktivität
Beschreibung
IC50 & Target
|
5-LO |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RBL-1 | IC50 |
23 nM
Compound: 14, (A-85761, ABT-761)
|
Compound was tested for in vitro inhibition against broken RBL-1.
Compound was tested for in vitro inhibition against broken RBL-1.
|
[PMID: 8709092] |
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 154355-76-7
-
Appearance Solid
-
Molecular Weight 318.37
-
Formel C16H15FN2O2S
-
Color White to off-white
-
SMILES
O=C(N)N([C@H](C)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)O
-
Synonyms
ABT-761; VIA-2291
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protokoll
-
EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
The EdU incorporation assay measures DNA synthesis by adding the thymidine analog 5-ethynyl-2′-deoxyuridine to cells or tissues, where it is incorporated into newly synthesized DNA during S phase. Incorporated EdU is detected by copper-catalyzed azide-alkyne cycloaddition, in which a fluorescent azide covalently reacts with the ethynyl group on EdU, allowing S-phase cells to be detected by fluorescence microscopy, flow cytometry, or high-content imaging. EdU detection does not require DNA denaturation or anti-BrdU antibody access, which preserves sample structure and improves compatibility with immunostaining and multiparameter cytometry compared with BrdU-based detection. EdU can be cytotoxic in a cell-type- and exposure-dependent manner, so pulse duration, concentration, and continuous-labeling designs should be validated for each cell type.
Reinheit & Dokumentation
-
Data Sheet (268 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Atreleuton Related Classifications
HY-117853 Related Classifications
Powered by Bioz